118 related articles for article (PubMed ID: 18210302)
1. Dose effects of continuous vinblastine chemotherapy on mammalian angiogenesis mediated by VEGF-A.
Albertsson P; Lennernäs B; Norrby K
Acta Oncol; 2008; 47(2):293-300. PubMed ID: 18210302
[TBL] [Abstract][Full Text] [Related]
2. On metronomic chemotherapy: modulation of angiogenesis mediated by VEGE-A.
Albertsson P; Lennernäs B; Norrby K
Acta Oncol; 2006; 45(2):144-55. PubMed ID: 16546859
[TBL] [Abstract][Full Text] [Related]
3. Antiangiogenic effect of metronomic paclitaxel treatment in prostate cancer and non-tumor tissue in the same animals: a quantitative study.
Lennernäs B; Albertsson P; Damber JE; Norrby K
APMIS; 2004 Mar; 112(3):201-9. PubMed ID: 15153162
[TBL] [Abstract][Full Text] [Related]
4. Low-dose continuous 5-fluorouracil infusion stimulates VEGF-A-mediated angiogenesis.
Albertsson P; Lennernäs B; Norrby K
Acta Oncol; 2009; 48(3):418-25. PubMed ID: 18932044
[TBL] [Abstract][Full Text] [Related]
5. The anti-tumour effect of low-dose continuous chemotherapy may partly be mediated by thrombospondin.
Damber JE; Vallbo C; Albertsson P; Lennernäs B; Norrby K
Cancer Chemother Pharmacol; 2006 Sep; 58(3):354-60. PubMed ID: 16333676
[TBL] [Abstract][Full Text] [Related]
6. Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy.
Drevs J; Fakler J; Eisele S; Medinger M; Bing G; Esser N; Marmé D; Unger C
Anticancer Res; 2004; 24(3a):1759-63. PubMed ID: 15274352
[TBL] [Abstract][Full Text] [Related]
7. Vinblastine inhibits the angiogenic response induced by adrenomedullin in vitro and in vivo.
Ribatti D; Guidolin D; Conconi MT; Nico B; Baiguera S; Parnigotto PP; Vacca A; Nussdorfer GG
Oncogene; 2003 Sep; 22(41):6458-61. PubMed ID: 14508526
[TBL] [Abstract][Full Text] [Related]
8. A pilot pharmacokinetic and antiangiogenic biomarker study of celecoxib and low-dose metronomic vinblastine or cyclophosphamide in pediatric recurrent solid tumors.
Stempak D; Gammon J; Halton J; Moghrabi A; Koren G; Baruchel S
J Pediatr Hematol Oncol; 2006 Nov; 28(11):720-8. PubMed ID: 17114958
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic (metronomic) chemotherapy for brain tumors: current and future perspectives.
Samuel DP; Wen PY; Kieran MW
Expert Opin Investig Drugs; 2009 Jul; 18(7):973-83. PubMed ID: 19548852
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic scheduling of lower dose cancer chemotherapy.
Gately S; Kerbel R
Cancer J; 2001; 7(5):427-36. PubMed ID: 11693902
[TBL] [Abstract][Full Text] [Related]
11. A low molecular weight polysaccharide isolated from Agaricus blazei suppresses tumor growth and angiogenesis in vivo.
Niu YC; Liu JC; Zhao XM; Wu XX
Oncol Rep; 2009 Jan; 21(1):145-52. PubMed ID: 19082455
[TBL] [Abstract][Full Text] [Related]
12. Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves radiation tumor therapy.
Timke C; Zieher H; Roth A; Hauser K; Lipson KE; Weber KJ; Debus J; Abdollahi A; Huber PE
Clin Cancer Res; 2008 Apr; 14(7):2210-9. PubMed ID: 18381963
[TBL] [Abstract][Full Text] [Related]
13. Metronomic dosing of chemotherapy: applications in pediatric oncology.
Stempak D; Seely D; Baruchel S
Cancer Invest; 2006; 24(4):432-43. PubMed ID: 16777697
[TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic and antiproliferative effects of substituted-1,3,4-oxadiazole derivatives is mediated by down regulation of VEGF and inhibition of translocation of HIF-1alpha in Ehrlich ascites tumor cells.
Kumar A; D'Souza SS; Nagaraj SR; Gaonkar SL; Salimath BP; Rai KM
Cancer Chemother Pharmacol; 2009 Nov; 64(6):1221-33. PubMed ID: 19370348
[TBL] [Abstract][Full Text] [Related]
15. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
16. Tumor escape from endogenous, extracellular matrix-associated angiogenesis inhibitors by up-regulation of multiple proangiogenic factors.
Fernando NT; Koch M; Rothrock C; Gollogly LK; D'Amore PA; Ryeom S; Yoon SS
Clin Cancer Res; 2008 Mar; 14(5):1529-39. PubMed ID: 18316578
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic effect of ZSTK474, a novel phosphatidylinositol 3-kinase inhibitor.
Kong D; Okamura M; Yoshimi H; Yamori T
Eur J Cancer; 2009 Mar; 45(5):857-65. PubMed ID: 19144509
[TBL] [Abstract][Full Text] [Related]
18. Low-dosage metronomic chemotherapy and angiogenesis: topoisomerase inhibitors irinotecan and mitoxantrone stimulate VEGF-A-mediated angiogenesis.
Albertsson P; Lennernäs B; Norrby K
APMIS; 2012 Feb; 120(2):147-56. PubMed ID: 22229270
[TBL] [Abstract][Full Text] [Related]
19. mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor.
Lane HA; Wood JM; McSheehy PM; Allegrini PR; Boulay A; Brueggen J; Littlewood-Evans A; Maira SM; Martiny-Baron G; Schnell CR; Sini P; O'Reilly T
Clin Cancer Res; 2009 Mar; 15(5):1612-22. PubMed ID: 19223496
[TBL] [Abstract][Full Text] [Related]
20. Broad antitumor activity in breast cancer xenografts by motesanib, a highly selective, oral inhibitor of vascular endothelial growth factor, platelet-derived growth factor, and Kit receptors.
Coxon A; Bush T; Saffran D; Kaufman S; Belmontes B; Rex K; Hughes P; Caenepeel S; Rottman JB; Tasker A; Patel V; Kendall R; Radinsky R; Polverino A
Clin Cancer Res; 2009 Jan; 15(1):110-8. PubMed ID: 19118038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
